BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 16948826)

  • 1. UVA1 phototherapy for cutaneous diseases: an experience of 92 cases in the United States.
    Tuchinda C; Kerr HA; Taylor CR; Jacobe H; Bergamo BM; Elmets C; Rivard J; Lim HW
    Photodermatol Photoimmunol Photomed; 2006 Oct; 22(5):247-53. PubMed ID: 16948826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of UVA1 phototherapy in 230 patients with various skin diseases.
    Rombold S; Lobisch K; Katzer K; Grazziotin TC; Ring J; Eberlein B
    Photodermatol Photoimmunol Photomed; 2008 Feb; 24(1):19-23. PubMed ID: 18201353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term efficacy of medium-dose UVA1 phototherapy in atopic dermatitis.
    Abeck D; Schmidt T; Fesq H; Strom K; Mempel M; Brockow K; Ring J
    J Am Acad Dermatol; 2000 Feb; 42(2 Pt 1):254-7. PubMed ID: 10642681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medium dose long-wavelength ultraviolet A (UVA1) phototherapy for the treatment of acute and chronic graft-versus-host disease of the skin.
    Wetzig T; Sticherling M; Simon JC; Hegenbart U; Niederwieser D; Al-Ali HK
    Bone Marrow Transplant; 2005 Mar; 35(5):515-9. PubMed ID: 15665847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medium-dose ultraviolet (UV) A1 vs. narrowband UVB phototherapy in atopic eczema: a randomized crossover study.
    Gambichler T; Othlinghaus N; Tomi NS; Holland-Letz T; Boms S; Skrygan M; Altmeyer P; Kreuter A
    Br J Dermatol; 2009 Mar; 160(3):652-8. PubMed ID: 19120333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-dose versus medium-dose UVA1 phototherapy for patients with severe generalized atopic dermatitis.
    Tzaneva S; Seeber A; Schwaiger M; Hönigsmann H; Tanew A
    J Am Acad Dermatol; 2001 Oct; 45(4):503-7. PubMed ID: 11568738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful ultraviolet A1 phototherapy in the treatment of localized scleroderma: a retrospective and prospective study.
    Andres C; Kollmar A; Mempel M; Hein R; Ring J; Eberlein B
    Br J Dermatol; 2010 Feb; 162(2):445-7. PubMed ID: 19785603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized controlled study of low-dose UVA1, medium-dose UVA1, and narrowband UVB phototherapy in the treatment of localized scleroderma.
    Kreuter A; Hyun J; Stücker M; Sommer A; Altmeyer P; Gambichler T
    J Am Acad Dermatol; 2006 Mar; 54(3):440-7. PubMed ID: 16488295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mononuclear cells in atopic dermatitis in vivo: immunomodulation of the cutaneous infiltrate by medium-dose UVA1 phototherapy.
    Breuckmann F; von Kobyletzki G; Avermaete A; Pieck C; Kreuter A; Brockmeyer NH; Altmeyer P; Gambichler T
    Eur J Med Res; 2002 Jul; 7(7):315-22. PubMed ID: 12176681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Narrowband ultraviolet B and medium-dose ultraviolet A1 are equally effective in the treatment of moderate to severe atopic dermatitis.
    Majoie IM; Oldhoff JM; van Weelden H; Laaper-Ertmann M; Bousema MT; Sigurdsson V; Knol EF; Bruijnzeel-Koomen CA; de Bruin-Weller MS
    J Am Acad Dermatol; 2009 Jan; 60(1):77-84. PubMed ID: 19103360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Narrowband ultraviolet-B phototherapy for hand and foot dermatoses.
    Kuhl JT; Davis MD; McEvoy MT
    Photodermatol Photoimmunol Photomed; 2008 Jun; 24(3):152-3. PubMed ID: 18477136
    [No Abstract]   [Full Text] [Related]  

  • 12. UVA/UVB phototherapy for atopic dermatitis revisited.
    Valkova S; Velkova A
    J Dermatolog Treat; 2004 Jul; 15(4):239-44. PubMed ID: 15764039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of a novel 308-nm monochromatic excimer light delivery system in dermatology: a pilot study in different chronic localized dermatoses.
    Aubin F; Vigan M; Puzenat E; Blanc D; Drobacheff C; Deprez P; Humbert P; Laurent R
    Br J Dermatol; 2005 Jan; 152(1):99-103. PubMed ID: 15656808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ultraviolet A1 (340-400 nm) phototherapy for scleroderma in systemic sclerosis.
    Morita A; Kobayashi K; Isomura I; Tsuji T; Krutmann J
    J Am Acad Dermatol; 2000 Oct; 43(4):670-4. PubMed ID: 11004624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. UVA1 phototherapy for disseminated granuloma annulare.
    Schnopp C; Tzaneva S; Mempel M; Schulmeister K; Abeck D; Tanew A
    Photodermatol Photoimmunol Photomed; 2005 Apr; 21(2):68-71. PubMed ID: 15752123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. UVA1 phototherapy: a review of mechanism and therapeutic application.
    York NR; Jacobe HT
    Int J Dermatol; 2010 Jun; 49(6):623-30. PubMed ID: 20618465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful UVA1 phototherapy in a patient with scleredema adultorum.
    Eberlein-König B; Vogel M; Katzer K; Hein R; Köhn FM; Ring J; Abeck D
    J Eur Acad Dermatol Venereol; 2005 Mar; 19(2):203-4. PubMed ID: 15752291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Narrowband ultraviolet B (UVB) phototherapy in children.
    Jury CS; McHenry P; Burden AD; Lever R; Bilsland D
    Clin Exp Dermatol; 2006 Mar; 31(2):196-9. PubMed ID: 16487089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 'High dose' vs. 'medium dose' UVA1 phototherapy in italian patients with severe atopic dermatitis.
    Pacifico A; Iacovelli P; Damiani G; Ferraro C; Cazzaniga S; Conic RRZ; Leone G; Morrone A
    J Eur Acad Dermatol Venereol; 2019 Apr; 33(4):718-724. PubMed ID: 30468530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment regimens, protocols, dosage, and indications for UVA1 phototherapy: facts and controversies.
    Gambichler T; Terras S; Kreuter A
    Clin Dermatol; 2013; 31(4):438-454. PubMed ID: 23806161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.